FDA approves Cyramza for hepatocellular carcinoma previously treated with sorafenib May 13, 2019 No Comments
Waylivra receives conditional marketing authorization from the European Commission May 8, 2019 No Comments
FDA approves Ruzurgi for pediatric patients with Lambert-Eaton myasthenic syndrome May 7, 2019 No Comments
FDA approves Kadcyla for adjuvant treatment in HER2-positive early breast cancer setting May 6, 2019 No Comments
RSS